Evaluating the Association between CCR5delta32 Polymorphism (rs333) and the Risk of Breast Cancer in a Cohort of Iranian Population

BACKGROUND: CC chemokine receptor 5 (CCR5) is introduced as an immune response modulator. The activity of CCR5 influences breast tumour development in a p53-dependent manner. This study aimed to investigate the frequency of CCR5delta32 and its association with the risk of breast cancer in 1038 blood...

Descripción completa

Detalles Bibliográficos
Autores principales: TAJBAKHSH, Amir, FARJAMI, Zahra, NESAEI-BAJESTANI, Abolfazl, AFZALJAVAN, Fahimeh, RIVANDI, Mahdi, MOEZZI, Atefeh, ABEDINI, Soheila, ASGHARI, Mahla, KOOSHYAR, Mohammad Mahdi, HOMAEI SHANDIZ, Fatemeh, PASDAR, Alireza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214612/
https://www.ncbi.nlm.nih.gov/pubmed/34178806
http://dx.doi.org/10.18502/ijph.v50i3.5604

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214612/
https://www.ncbi.nlm.nih.gov/pubmed/34178806
http://dx.doi.org/10.18502/ijph.v50i3.5604

Ejemplares similares